Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference

Rhea-AI Summary

Wave Life Sciences Ltd. (Nasdaq: WVE) announced that CEO Paul Bolno will present at the Chardan Virtual 4th Annual Genetic Medicines Conference on October 6, 2020, at 4:45 p.m. ET. A live webcast of the presentation will be available on the company's Investor Relations page, with a replay accessible for 90 days post-event. Wave is dedicated to developing transformative genetic medicines using its proprietary PRISM platform to target genetically defined diseases, aiming to improve patients' futures.

CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Tuesday, October 6, 2020 at 4:45 p.m. ET.

A live webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contacts:
Kate Rausch
617-949-4827
krausch@wavelifesci.com

Graham Morrell
781-686-9600
gmorrell@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

 

FAQ

When will Paul Bolno present at the Chardan Virtual Conference for Wave Life Sciences?

Paul Bolno will present on October 6, 2020, at 4:45 p.m. ET.

Where can I watch the Wave Life Sciences presentation live?

You can watch the live presentation on the Investor Relations page of Wave Life Sciences' website.

How long will the replay of the Wave Life Sciences presentation be available?

The replay of the presentation will be available for 90 days after the event.

What is the focus of Wave Life Sciences as a company?

Wave Life Sciences focuses on delivering life-changing genetic medicines for patients with genetically defined diseases.